Top compounds associated with response to CD6


Feature Type Standardized
Nominal ANOVA
mRNA alvocidib CTRPv2 pan-cancer AAC 0.017 0.7
mRNA tivozanib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA TW 37 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA KH-CB19 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA linifanib GDSC1000 pan-cancer AAC -0.012 0.7
mRNA JW-55 CTRPv2 pan-cancer AAC -0.025 0.7
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.012 0.7
mRNA GDC-0449 FIMM pan-cancer AAC -0.058 0.7
Download CSV